As of 2025-05-16, the EV/EBITDA ratio of Armata Pharmaceuticals Inc (ARMP) is -3.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARMP's latest enterprise value is 135.76 mil USD. ARMP's TTM EBITDA according to its financial statements is -41.11 mil USD. Dividing these 2 quantities gives us the above ARMP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-14 | -3.28 |
| 2025-05-13 | -3.32 |
| 2025-05-12 | -3.21 |
| 2025-05-09 | -3.21 |
| 2025-05-08 | -3.27 |
| 2025-05-07 | -3.28 |
| 2025-05-06 | -3.28 |
| 2025-05-05 | -3.42 |
| 2025-05-02 | -3.33 |
| 2025-05-01 | -3.25 |
| 2025-04-30 | -3.47 |
| 2025-04-29 | -3.42 |
| 2025-04-28 | -3.31 |
| 2025-04-25 | -3.32 |
| 2025-04-24 | -3.26 |
| 2025-04-23 | -3.23 |
| 2025-04-22 | -3.22 |
| 2025-04-21 | -3.16 |
| 2025-04-17 | -3.15 |
| 2025-04-16 | -3.11 |
| 2025-04-15 | -3.08 |
| 2025-04-14 | -3.09 |
| 2025-04-11 | -2.91 |
| 2025-04-10 | -2.87 |
| 2025-04-09 | -2.91 |
| 2025-04-08 | -3.05 |
| 2025-04-07 | -3.17 |
| 2025-04-04 | -3.20 |
| 2025-04-03 | -3.23 |
| 2025-04-02 | -3.21 |
| 2025-04-01 | -3.34 |
| 2025-03-31 | -3.36 |
| 2025-03-28 | -3.46 |
| 2025-03-27 | -3.52 |
| 2025-03-26 | -3.52 |
| 2025-03-25 | -3.55 |
| 2025-03-24 | -3.69 |
| 2025-03-21 | -3.65 |
| 2025-03-20 | -3.84 |
| 2025-03-19 | -3.82 |
| 2025-03-18 | -3.87 |
| 2025-03-17 | -3.87 |
| 2025-03-14 | -3.79 |
| 2025-03-13 | -3.80 |
| 2025-03-12 | -3.73 |
| 2025-03-11 | -3.72 |
| 2025-03-10 | -3.83 |
| 2025-03-07 | -3.85 |
| 2025-03-06 | -3.92 |
| 2025-03-05 | -3.85 |